(Q28174827)

English

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

scientific article (publication date: 2001)

In more languages

edit

Statements

0 references

1 reference

Europe PubMed Central

title

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans (English)

0 references

1 reference

C J Hawkey

1

0 references

L Jackson

series ordinal

2

0 references

S E Harper

series ordinal

3

0 references

T J Simon

series ordinal

4

0 references

E Mortensen

series ordinal

5

0 references

C R Lines

series ordinal

6

0 references

language of work or name

English

0 references

publication date

January 2001

0 references

published in

Alimentary Pharmacology & Therapeutics

0 references

volume

15

0 references

issue

1

0 references

page(s)

1-9

0 references

cites work

Toward an epidemiology of gastropathy associated with nonsteroidal antiinflammatory drug use.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Gastrointestinal toxicity of nonsteroidal antiinflammatory drugs.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Recent considerations in nonsteroidal anti-inflammatory drug gastropathy

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Nonsteroid drug selectivities for cyclo-oxygenase-1 rather than cyclo-oxygenase-2 are associated with human gastrointestinal toxicity: a full in vitro analysis

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Rofecoxib, a specific cyclooxygenase-2 inhibitor, in primary dysmenorrhea: a randomized controlled trial

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

A randomized trial comparing the effect of rofecoxib, a cyclooxygenase 2-specific inhibitor, with that of ibuprofen on the gastroduodenal mucosa of patients with osteoarthritis. Rofecoxib Osteoarthritis Endoscopy Study Group

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Comparison of the effect of rofecoxib (a cyclooxygenase 2 inhibitor), ibuprofen, and placebo on the gastroduodenal mucosa of patients with osteoarthritis: a randomized, double-blind, placebo-controlled trial. The Rofecoxib Osteoarthritis Endoscopy M

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Effects of inhibition of prostaglandin endoperoxide synthase-2 in chronic gastro-intestinal ulcer models in rats

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00894.X

retrieved

21 January 2018

Identifiers

DOI

10.1046/J.1365-2036.2001.00894.X

0 references

PubMed publication ID

11136272

0 references

ResearchGate publication ID

12193261

0 references

(Q28174827)

Review article: the gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase-2, in humans

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)